influenza
viru
major
caus
acut
respiratori
diseas
human
respons
approxim
death
annual
worldwid
pandem
influenza
viru
infect
result
signific
morbid
mortal
first
outbreak
influenza
report
sinc
affect
multipl
countri
sever
season
strain
preval
cocircul
viral
subtyp
high
morbid
mortal
rate
influenza
nomenclatur
base
genotyp
properti
two
surfac
glycoprotein
hemagglutinin
ha
neuraminidas
na
current
ha
na
subtyp
recogn
primari
target
host
neutral
antibodi
ha
glycoprotein
inhibit
bind
sialic
acid
receptor
present
respiratori
tract
five
identifi
antigen
site
name
b
c
e
nonrecognit
strain
neutral
antibodi
present
host
consequ
mutat
site
continu
buildup
mutat
antigen
site
basi
evolutionari
dynam
observ
influenza
viru
result
antigen
drift
seven
clade
design
clade
mani
subclad
evolv
past
year
provid
signific
challeng
annual
design
effect
influenza
vaccin
present
virus
clade
domin
group
diversifi
three
major
subclad
design
subclad
contain
sever
distinguish
genet
group
best
strategi
reduc
burden
influenza
vaccin
whose
efficaci
vari
respect
circul
strain
although
influenza
vaccin
limit
africa
particularli
subsaharan
africa
previou
report
introduct
virus
undergon
drift
due
antivir
vaccin
pressur
region
therefor
crucial
need
monitor
genet
antigen
characterist
well
drug
suscept
influenza
virus
compon
pandem
prepared
better
understand
molecular
evolut
influenza
assess
vaccin
efficaci
cameroon
three
gene
segment
character
respiratori
sampl
collect
januari
june
outpati
clinic
evid
influenzalik
ill
ili
defin
person
sudden
onset
fever
cough
sore
throat
sentinel
site
involv
influenza
surveil
cameroon
nasopharyng
andor
oropharyng
swab
collect
put
ml
cryovial
contain
viru
transport
medium
store
transport
pasteur
centr
cameroon
pcc
analysi
sampl
store
anonym
studi
specif
approv
cameroon
nation
ethic
committe
viral
rna
extract
clinic
sampl
qiagen
rna
kit
accord
manufactur
instruct
final
volum
elut
buffer
extract
analyz
presenc
influenza
realtim
revers
transcriptionpolymeras
chain
reaction
rtpcr
abi
prism
thermocycl
appli
biosystem
foster
citi
california
usa
posit
sampl
influenza
ct
subtyp
elig
sequenc
conveni
sampl
size
randomli
select
flu
databas
base
geograph
origin
distribut
time
sampl
coinfect
influenza
subtyp
includ
first
pcr
perform
use
superscript
iii
one
step
rtpcr
system
invitrogen
carlsbad
usa
set
primer
tabl
follow
procedur
use
amplif
bp
ha
gene
na
gene
bp
gene
influenza
overal
total
reaction
volum
contain
follow
reagent
pcr
buffer
forward
revers
primer
rnasin
superscript
rtplatinum
taq
enzym
rna
mixtur
run
use
follow
program
ha
gene
cycl
na
gene
follow
program
use
cycl
cycl
first
pcr
product
use
templat
seminest
pcr
total
reaction
volum
contain
water
pcr
buffer
mm
dntp
mix
mm
mm
forward
revers
primer
taq
dna
polymeras
first
pcr
product
mixtur
run
use
follow
program
gene
segment
cycl
pcr
product
run
gel
band
correspond
appropri
size
sent
sequenc
genewiz
uk
ltd
hope
end
uk
correspond
primer
set
sequenc
edit
assembl
clc
main
workbench
version
sequenc
refer
strain
known
clade
northern
hemispher
vaccin
strain
recommend
includ
phylogenet
analysi
obtain
genbank
gisaid
databas
phylogenet
tree
code
nucleotid
sequenc
gener
mega
version
use
neighborjoin
method
number
bootstrap
replic
set
bootstrap
valu
label
major
tree
branch
refer
amino
acid
residu
epitop
e
influenza
previous
identifi
influenza
viru
sequenc
includ
analysi
submit
genbank
access
number
tabl
provid
detail
inform
cameroon
influenza
gene
sequenc
predict
potenti
nlike
glycosyl
site
perform
onlin
server
netnglyc
server
consid
amino
acid
align
asnxserthr
x
amino
acid
except
asp
pro
threshold
valu
suggest
glycosyl
predict
vaccin
efficaci
influenza
season
influenza
viru
estim
use
pepitop
method
pepitop
measur
antigen
distanc
vaccin
strain
domin
circul
strain
calcul
follow
number
mutat
domin
epitop
number
amino
acid
domin
epitop
mathemat
formula
link
vaccin
efficaci
influenza
pepitop
given
e
pepitop
pepitop
vaccin
circul
strain
null
influenza
vaccin
efficaci
model
correl
best
vaccin
efficaci
compar
phylogenet
analys
antisera
hemagglutin
inhibit
assay
ha
code
sequenc
amino
acid
sequenc
cameroonian
viru
strain
analyz
comparison
gene
perform
strain
circul
n
n
n
season
sequenc
northern
hemispher
vaccin
refer
strain
phylogenet
analysi
show
cameroonian
viru
strain
evolv
away
clade
acquir
sever
amino
acid
substitut
fig
tabl
viru
strain
cluster
vaccin
strain
viru
strain
cluster
vaccin
strain
except
one
isol
cluster
refer
strain
viru
strain
differ
viru
strain
three
antigen
site
antigen
site
contain
amino
acid
substitut
antigen
site
b
show
substitut
antigen
site
c
show
substitut
compar
clade
tabl
isol
differ
viru
strain
studi
cluster
clade
strain
isol
differ
viru
strain
studi
substitut
isol
differ
strain
possess
substitut
na
sequenc
analysi
show
cameroonian
strain
evolv
away
clade
fig
strain
influenza
season
cluster
strain
viru
strain
cluster
strain
close
relat
vaccin
strain
respect
na
gene
viru
strain
differ
viru
strain
substitut
sever
amino
acid
found
viru
strain
wherea
substitut
found
viru
strain
analysi
gene
show
viru
strain
cluster
vaccin
strain
viru
strain
cluster
refer
strain
fig
global
signific
chang
observ
protein
cameroonian
strain
respect
refer
strain
one
isol
display
amino
acid
substitut
compar
vaccin
strain
order
determin
genotyp
antivir
drug
suscept
viru
strain
includ
studi
analyz
na
protein
code
sequenc
report
genet
marker
resist
neuraminidas
inhibitor
nai
oseltamivir
zanamivir
laninamivir
peramivir
adamantan
amantadin
rimantadin
mutat
na
protein
report
caus
reduc
suscept
nai
laid
emphasi
follow
substitut
delet
specif
associ
clinic
resist
neuraminidas
inhibitor
virus
none
strain
previous
report
mutat
peculiar
reduc
suscept
nai
howev
isol
amino
acid
substitut
posit
amino
acid
posit
transmembran
region
protein
residu
frequent
associ
amantadin
rimantadineresist
strain
amino
acid
site
check
follow
mutat
associ
reduc
suscept
resist
adamantan
strain
possess
amino
acid
substitut
predict
glycosyl
site
viru
strain
well
one
isol
amino
acid
posit
nst
ngt
nat
nss
nct
ngt
nvt
nst
ng
wherea
viru
strain
addit
glycosyl
site
posit
nwt
nyt
respect
due
substitut
assess
effect
accumul
mutat
domain
predict
vaccin
efficaci
given
year
pepitop
method
use
evalu
close
vaccin
strain
resembl
circul
strain
tabl
theoret
pepitop
domin
epitop
higher
vaccin
efficaci
becom
neg
sequenc
mostli
domin
mutat
epitop
b
pepitop
respect
vaccin
strain
suggest
latter
poorli
match
multipl
circul
strain
present
year
consequ
lead
neg
vaccin
efficaci
strain
e
pepitop
season
sequenc
show
antigen
drift
mainli
epitop
pepitop
strain
domin
epitop
substitut
predict
vaccin
efficaci
strain
e
pepitop
perfect
match
vaccin
strain
pepitop
strain
domin
epitop
mutat
predict
minimum
vaccin
efficaci
strain
e
pepitop
perfect
match
vaccin
strain
influenza
demonstr
antigen
drift
epitop
b
epitop
vaccin
strain
belong
clade
also
examin
abil
match
strain
clade
circul
result
pepitop
valu
gave
estim
worstcas
vaccin
efficaci
strain
moreov
clade
strain
season
vaccin
strain
show
valu
indic
worstcas
vaccin
efficaci
strain
first
report
genom
character
influenza
cameroon
analyz
code
sequenc
gene
segment
influenza
viru
strain
influenza
season
cameroon
compar
refer
strain
recommend
vaccin
strain
epidemiolog
relev
african
strain
genbank
gisaid
databas
observ
differ
phylogenet
cluster
gener
differ
gene
segment
ha
gene
sequenc
indic
cameroon
strain
evolv
away
clade
acquir
genet
marker
identifi
characterist
clade
marker
report
influenza
virus
isol
africa
cluster
cameroonian
strain
recommend
refer
vaccin
strain
northern
hemispher
clade
none
select
african
viru
strain
circul
cluster
clade
either
cameroonian
strain
form
two
distinct
cluster
viru
strain
cluster
clade
viru
strain
cluster
clade
interestingli
cameroonian
na
gene
sequenc
also
evolv
away
clade
acquir
sever
amino
acid
substitut
uniqu
isol
compar
mani
regard
viru
strain
howev
na
gene
unlik
remain
viru
strain
theoret
clear
vaccin
mismatch
observ
influenza
season
report
tewawong
et
al
southern
hemispher
sever
amino
acid
mutat
epitop
ha
gene
respons
drift
circul
strain
vaccin
strain
strain
corrobor
pepitop
observ
eventu
result
neg
vaccin
efficaci
vaccin
chang
strain
follow
season
result
circul
strain
cover
select
vaccin
notwithstand
poor
result
previou
influenza
season
select
vaccin
strain
show
moder
efficaci
compar
circul
viru
strain
noteworthi
vaccin
influenza
viru
common
phenomenon
cameroon
popul
howev
better
select
annual
vaccin
use
pepitop
suggest
author
improv
vaccin
efficaci
encourag
uptak
flu
vaccin
may
result
reduc
burden
caus
influenza
due
herd
immun
acquisit
mutat
influenza
virus
confer
resist
antivir
agent
may
occur
result
drug
select
spontan
mutat
genet
reassort
anoth
drug
resist
influenza
viru
neuraminidas
inhibitor
target
na
glycoprotein
play
key
role
product
new
viral
progeni
rare
report
resist
neuraminidas
inhibitor
influenza
viru
strain
confirm
cameroonian
viru
strain
absenc
previou
mutat
characterist
resist
howev
novel
amino
amino
acid
mutat
previous
report
investig
clinic
relev
mutat
essenti
better
understand
molecular
evolut
influenza
amantadin
resist
report
virus
worldwid
confirm
cameroonian
viru
strain
substitut
protein
high
preval
amantadin
resist
influenza
virus
observ
countri
irrespect
use
resist
inhibitor
first
appear
follow
extens
drug
use
asia
us
sar
sever
acut
respiratori
syndrom
epidem
sinc
histori
exposur
antivir
drug
influenza
eventu
adamantan
cameroonian
viru
strain
mutat
indic
strain
alreadi
harbour
drug
resist
mutat
like
introduc
commun
resist
strain
probabl
select
advantag
sensit
strain
favour
evolut
fit
report
mostafa
et
al
glycosyl
deglycosyl
import
viral
mechan
mask
antigen
epitop
thu
inhibit
bind
neutral
antibodi
ii
adjust
receptorbind
affin
iii
regul
virul
influenza
cameroonian
viru
strain
share
least
nine
potenti
nglycosyl
site
vaccin
strain
similar
glycosyl
pattern
group
strain
acquir
addit
glycosyl
site
predict
ha
glycosyl
pattern
may
contribut
potenti
antigen
escap
influenza
virus
antibodi
rais
vaccin
strain
previou
circul
strain
increas
viral
fit
yettobecharacter
mechan
presenc
sever
antigen
site
mutat
high
frequenc
among
viru
strain
influenza
season
confirm
progress
evolut
circul
strain
result
lay
emphasi
relev
routin
influenza
surveil
well
genet
antigen
character
facilit
prompt
effici
select
influenza
strain
includ
flu
vaccin
data
valuabl
track
phylogenet
evolut
influenza
virus
within
subsaharan
africa
